Gene therapy startup Jaguar set to join NC manufacturing boom with $125M facility
Jaguar Gene Therapy will join the North Carolina biotech manufacturing community, with a $125 million investment in a 174,000 square-foot facility that will sit down the road from the company’s Cary, NC laboratory.
The already-existing site will be converted to the company’s manufacturing specifications and support clinical and commercial manufacturing of its initial programs, including galactosemia, a specific genetic cause of autism, and Type 1 diabetes. The first therapies are likely to enter the clinic in 2023.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.